Plasma microRNA-100 as a biomarker of coronary plaque vulnerability – A new generation of biomarker for developing acute coronary syndrome

Circulation Journal

Volumn 79, Issue 2, 2015, Pages 303-304

  Izawa, Hideo ^a   Amano, Tetsuya ^b  

^a FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 1; MICRORNA 100; MICRORNA 126; MICRORNA 1291; MICRORNA 133; MICRORNA 145; MICRORNA 146A; MICRORNA 208; MICRORNA 21; MICRORNA 30A; MICRORNA 451; MICRORNA 499; MICRORNA 590 5P; MICRORNA 663B; UNCLASSIFIED DRUG; MICRORNA;

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR PARAMETERS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY PLAQUE VULNERABILITY; CORONARY SINUS; EDITORIAL; HISTOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; LIPID ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; BLOOD; FEMALE; MALE; PATHOPHYSIOLOGY;

CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MICRORNAS; PLAQUE, ATHEROSCLEROTIC;

EID: 84928229063     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1295     Document Type: Editorial

References (15)

1. van Rooij E, Olson EN. MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 2007; 117: 2369–2376.
2. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature2008; 455: 58–63.
3. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell2012; 148: 1172–1187.
4. Funahashi H, Izawa H, Hirashiki A, Cheng XW, Inden Y, Nomura M, et al. Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure. J Cardiol2011; 57: 338–344.
5. Long G, Wang F, Li H, Yin Z, Sandip C, Lou Y, et al. Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. BMC Neurol2013; 13: 178.
6. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res2010; 107: 677–684.
7. De Rosa S, Curcio A, Indolf C. Emerging role of microRNAs in cardiovascular diseases. Circ J2014; 78: 567–575.
8. Guo M, Mao X, Ji Q, Lang M, Li S, Peng Y, et al. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol Cell Biol2010; 88: 555–564.
9. Soeki T, Yamaguchi K, Niki T, Uematsu E, Bando S, Matsuura T, et al. Plasma microRNA-100 is associated with coronary plaque vulnerability. Circ J2015; 79: 413–418.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathologenesi-sof coronary artery disease and acute coronary syndrome. N Engl J Med1992; 326: 242–250.
11. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation2002; 105: 939–943.
12. Sano K, Kawasaki M, Ishihara Y, Okubo M, Tsuchiya K, Nishigaki K, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol2006; 47: 734–741.
13. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Impact of metabolic syndrome on tissue characteristics of angiographically mild to moderate coronary lesions: Integrated backscatter intravascular ultrasound study. J Am Coll Cardiol2007; 49: 1149–1156.
14. Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, et al. Abnormal glucose regulation is associated with lipid-rich coronary plaque: Relationship to insulin resistance. JACC Cardiovasc Imaging2008; 1: 39–45.
15. Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis. Cancer Sci2010; 101: 2087–2092.